Compound information
- Natural Products
- ZC2042871
- Molecular Formula
- C23H33N3O6S
- Molecular Weight
- 479.209006776 g/mol
- Structure
-
- IUPAC Name
- (2S)-2-(tert-butoxycarbonylamino)-6-[[5-(dimethylamino)-1-naphthyl]sulfonylamino]hexanoic acid
- InChI
- InChI=1S/C23H33N3O6S/c1-23(2,3)32-22(29)25-18(21(27)28)12-6-7-15-24-33(30,31)20-14-9-10-16-17(20)11-8-13-19(16)26(4)5/h8-11,13-14,18,24H,6-7,12,15H2,1-5H3,(H,25,29)(H,27,28)/t18-/m0/s1
- InChI Key
- WBXVVSQZXDFRRT-SFHVURJKSA-N
- SMILES
- CN(C)c1cccc2c(S(=O)(=O)NCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)O)cccc12
- Source
- ZINC000039146041
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 33 | Ring Count | 2 |
Heteroatom Count | 10 | Rotatable Bond Count | 10 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 125.04 Å2 | LogP | 3.32 |
LogS | -3.901 | LogD | 2.765 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.002 | Pgp substrate | 0.878 |
HIA | 0.534 | F20 % | 0.73 |
F30 % | 0.934 | Caco-2 | -6.602 |
MDCK | -5.927 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.35 | PPB | 83.642 |
VD | 0.895 | Fu | 0.994 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.476 |
CYP2A6 substrate | 0.427 | CYP2B6 substrate | 0.543 |
CYP2C19 inhibitor | 0.183 | CYP2C19 substrate | 0.869 |
CYP2C8 substrate | 0.748 | CYP2C9 inhibitor | 0.456 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.032 |
CYP2D6 substrate | 0.921 | CYP2E1 substrate | 0.378 |
CYP3A4 inhibitor | 0.008 | CYP3A4 substrate | 0.995 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.558 | CL | 1.748 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.039 | Hepatotoxicity | 0.781 |
Mutagenicity | 0.054 | Rat Oral Acute Toxicity | 0.051 |
FDAMDD | 0.076 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.004 | Eye Corrosion | 0.001 |
Eye Irritation | 0.008 | Respiratory Toxicity | 0.032 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.382 | IGC50 | 1.965 |
LC50FM | 3.249 | LC50DM | 3.715 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.364 | NR-AR-LBD | 0.365 |
NR-AhR | 0.225 | NR-Aromatase | 0.245 |
NR-ER | 0.513 | NR-ER-LBD | 0.487 |
NR-PPAR-gamma | 0.843 | SR-ARE | 0.707 |
SR-ATAD5 | 0.412 | SR-HSE | 0.03 |
SR-MMP | 0.035 | SR-p53 | 0.117 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.